Zantac / Ranitidine (NDMA Cancer) Attorney in Nashville, Tennessee

Zantac Litigation in Nashville — URGENT SOL Warning

Tennessee's 1-year statute of limitations for personal injury claims is one of the shortest in the country. Nashville-area Zantac claimants with a cancer diagnosis linked to ranitidine use MUST consult an attorney immediately — within weeks, not months, of diagnosis. Tennessee applies Daubert under Tenn. R. Evid. 702, making Tennessee state court similar to federal court for causation expert purposes. National plaintiffs' counsel strongly recommend filing in Delaware Superior Court as the primary venue for Tennessee claimants. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Nashville Zantac Claimants

Nashville-area Zantac claimants should immediately gather pharmacy records from Walgreens, CVS, Kroger, and employer/HCA Healthcare pharmacy programs. Vanderbilt-Ingram Cancer Center records documenting bladder, esophageal, stomach, or colorectal cancer diagnosis are critical. Given Tennessee's 1-year SOL, waiting even a few months can result in claim forfeiture — contact qualified Zantac plaintiffs' counsel today.